2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C

2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C

Bibliographic Details
Format:	Article
Language:	English
Published:	Korean Association for the Study of the Liver 2018-09-01
Series:	Clinical and Molecular Hepatology
Subjects:	Chronic hepatitis C Treatment Direct acting antivirals Guidelines
Online Access:	http://e-cmh.org/upload/pdf/cmh-2018-1004.pdf

Similar Items

2017 Korean Association for the Study of the Liver (KASL) Clinical Practice Guidelines of Chronic Hepatitis C: WhatGraves’s New?
by: Kyung-Ah Kim
Published: (2018-06-01)

KASL clinical practice guidelines: Management of Hepatitis C
Published: (2014-06-01)

KASL clinical practice guidelines for management of chronic hepatitis B
Published: (2019-06-01)

KASL clinical practice guidelines: management of hepatitis C
Published: (2016-03-01)

KASL clinical practice guidelines for management of chronic hepatitis B
Published: (2022-04-01)

KASL Clinical Practice Guidelines: Management of chronic hepatitis B
Published: (2012-06-01)

KASL clinical practice guidelines: management of chronic hepatitis B
Published: (2016-03-01)

Chronic Hepatitis C Treatment with New Antiviral Agents
by: Özlem KANDEMİR
Published: (2018-12-01)

Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL
by: Jong Eun Yeon
Published: (2018-09-01)

KASL clinical practice guidelines for management of autoimmune hepatitis 2022
Published: (2023-07-01)

Current Treatment Of Chronıc Hepatıtıs C Genotype 1
by: Mesut Aydın, et al.
Published: (2018-10-01)

Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? – Indications for Treatment
by: Kyung-Ah Kim
Published: (2016-03-01)

Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
by: Chung-Feng Huang, et al.
Published: (2020-07-01)

Hepatitis C Treatment: A Review and Update
by: Jelena Jakab, et al.
Published: (2017-04-01)

2018 Korean Association for the Study of the Liver (KASL) Clinical Practice Guidelines of Chronic Hepatitis B: What’s Different?
by: Ji Hoon Kim
Published: (2019-03-01)

Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea
by: Yuri Cho, et al.
Published: (2015-12-01)

Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals
by: Soon Young Ko, et al.
Published: (2018-12-01)

The Australasian Hepatology Association consensus guidelines for the provision of adherence support to patients with hepatitis C on direct acting antivirals
by: Richmond JA, et al.
Published: (2016-12-01)

SASLT practice guidelines: Management of hepatitis C virus infection
by: Abdullah S Alghamdi, et al.
Published: (2012-01-01)

A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C): protocol for a prospective treatment registry of real-world outcomes for hepatitis C
by: Jessica Ramsay, et al.
Published: (2020-10-01)

NOVEL DIRECT ACTING ANTIVIRAL REGIMENS FOR PATIENTS WITH CHRONIC HEPATITIS C AND CHRONIC KIDNEY DISEASE STAGE 3 TO STAGE 5D
by: Nauman Kashif, et al.
Published: (2020-08-01)

Sofosbuvir and Ribavirin in Chronic Hepatitis C Virus Patients with No Response or Relapse with Interferon Therapy
by: Shaimuna Fareeha Sajjad, et al.
Published: (2020-12-01)

New treatment of hepatitis C (Direct Acting Antiviral)
by: Mohsen Akhondi-Meybodi
Published: (2019-10-01)

Comparison of the Rate of APRI, Which is an Indirect Indicator of Hepatic Fibrosis, Before and After Treatment in Chronic Hepatitis C Patients with Sustained Viral Response
by: Süleyman COŞGUN, et al.
Published: (2022-09-01)

Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017
by: Christer F. Aas, et al.
Published: (2020-06-01)

Planning a clinical trial programme for direct-acting antivirals for chronic viral hepatitis C
by: A. I. Gubenko, et al.
Published: (2023-12-01)

Antiviral therapy in chronic hepatitis C virus infection
by: Irina Russu
Published: (2019-09-01)

Successful Treatment for Chronic Hepatitis C-Autoimmune Hepatitis Overlap Syndrome due to Daclatasvir and Asunaprevir
by: Ayumi Sugiura, et al.
Published: (2017-05-01)

Direct-Acting Antiviral Agents for Hepatitis C Virus Infection—From Drug Discovery to Successful Implementation in Clinical Practice
by: Christopher Dietz, et al.
Published: (2022-06-01)

Are There Still Difficult-to-Treat Patients with Chronic Hepatitis C in the Era of Direct-Acting Antivirals?
by: Paweł Pabjan, et al.
Published: (2022-01-01)

Hepatitis C treatment: where are we now?
by: Burstow NJ, et al.
Published: (2017-02-01)

Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C Treated with Direct-Acting Antivirals
by: Cassia Leal, et al.
Published: (2023-01-01)

Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
by: Ghaydaa A. Shehata, et al.
Published: (2022-12-01)

Adolescents with chronic hepatitis C might be good candidates for direct‐acting antiviral therapy
by: Ken Sato, et al.
Published: (2022-04-01)

The effect of direct acting antiviral agents on vascular endothelial function in Egyptian patients with chronic hepatitis C virus infection
by: Dalia A Freekh, et al.
Published: (2021-10-01)

A real-life study of the positive response to DAA-based therapies for hepatitis C in Brazil
by: Simone Monzani Vivaldini, et al.
Published: (2021-03-01)

Chronic hepatitis C virus infection: An internist’s opinion (Part 1)
by: M L Zubkin, et al.
Published: (2016-10-01)

The impact of direct-acting antivirals on quality of life in patients with hepatitis C virus infection: a meta-analysis
by: Na He, et al.
Published: (2022-07-01)

KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications
Published: (2020-04-01)

Efficacy and safety of daclatasvir-containing regimens in the treatment of chronic hepatitis C patients in Damietta
by: Alaa Eldeen M Hashim, et al.
Published: (2020-01-01)